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Purpose: Computed tomography (CT) is used for initial diagnosis and therapy monitoring of patients with 
coronavirus disease 2019 (COVID-19). As patients of all ages are affected, radiation dose is a concern. While 
follow-up CT examinations lead to high cumulative radiation doses, the ALARA principle states that the applied 
dose should be as low as possible while maintaining adequate image quality. The aim of this study was to 
evaluate parameter settings for two commonly used CT scanners to ensure sufficient image quality/diagnostic 
confidence at a submillisievert dose. 
Materials and methods: We retrospectively analyzed 36 proven COVID-19 cases examined on two different 
scanners. Image quality was evaluated objectively as signal-to-noise ratio (SNR)/contrast-to-noise ratio (CNR) 
measurement and subjectively by two experienced, independent readers using 3-point Likert scales. CT dose 
index volume (CTDIvol) and dose-length product (DLP) were extracted from dose reports, and effective dose was 
calculated. 
Results: With the tested parameter settings we achieved effective doses below 1 mSv (median 0.5 mSv, IQR: 0.2 
mSv, range: 0.3− 0.9 mSv) in all 36 patients. Thirty-four patients had typical COVID-19 findings. Both readers 
were confident regarding the typical COVID-19 CT-characteristics in all cases (3 ± 0). Objective image quality 
parameters were: SNRnormal lung: 17.0 ± 5.9, CNRGGO/normal lung: 7.5 ± 5.0, and CNRconsolidation/normal lung: 15.3 ±
6.1. 
Conclusion: With the tested parameters, we achieved applied doses in the submillisievert range, on two different 
CT scanners without sacrificing diagnostic confidence regarding COVID-19 findings.   
1. Introduction 
The new coronavirus (SARS-CoV-2) and the disease it causes 
(COVID-19) were first reported in the city of Wuhan, China, in 
December 2019 [1,2]. In most cases, SARS-CoV-2 manifests with only 
mild symptoms, but some patients develop a severe disease, which can 
lead to acute respiratory distress syndrome (ARDS), multiple organ 
failure, and death [3,4]. 
There are specific pulmonary findings associated with COVID-19 in 
chest computed tomography (CT), including bilateral ground-glass 
opacities (GGO) with peripheral distribution, consolidations, and the 
“crazy-paving” pattern or “reverse halo” sign [5–13]. In the course of the 
disease, CT can show these typical changes, even if no virus is detected 
in the nasopharyngeal or throat swab [14,15]. Reverse transcription 
polymerase chain reaction (RT-PCR) testing is limited by a longer 
waiting time for results. Therefore, CT imaging can speed up diagnosis of 
COVID-19 and provide valuable findings in the further course of disease 
[16]. Kang et al. even recommended low-dose CTs for initial diagnosis 
and to monitor the course of COVID-19 [14]. They underline that a CT 
can be very helpful early at the onset of symptoms or when the swab test 
is negative [14,15]. Esposito et al. also conclude that chest CT is a good 
and fast imaging modality for first-line triage of patients with suspected 
COVID-19 [17]. Radpour et al. focus on the advantages of low-dose CT 
especially in regions with many patients and limited availability of 
RT-PCR tests [18]. Nevertheless, the results should be interpreted with 
caution, as they depend on the disease status, testing method, and im-
aging technique (e.g., applied dose). 
As all age groups are affected by COVID-19 according to a multi- 
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center study of Yang et al., which was also summarized in an article of Yi 
et al. [19], the potential risks arising from the radiation dose associated 
with CT need to be addressed [14] as findings like GGO are sometimes 
not visible in chest radiographs [20]. Nevertheless, the diagnostic con-
fidence of chest CT must be guaranteed regarding typical pulmonary 
findings associated with COVID-19. 
The aim of this study was therefore, based on experiences of a 
German center, to evaluate parameter settings for two commonly used 
CT scanners that potentially ensure sufficient image quality/diagnostic 
confidence regarding COVID-19 findings at submillisievert dose levels. 
2. Materials and methods 
2.1. Study design/patient cohort 
This retrospective study was approved by the Local Ethics Committee 
of our hospital (EA4/074/20). Based on published data and our expe-
rience, we selected acquisition parameters for low-dose chest scans in 
patients with suspected COVID-19 (see Table 1) examined on two 
scanners from different vendors. We retrospectively included 36 patients 
from two sites (n = 17/19) of our German Level-I university center, who 
were treated between March 30 and April 22, 2020. All patients 
included were positive for SARS-CoV-2 (RT-PCR of nasopharyngeal and 
oropharyngeal swab samples; patients with a negative RT-PCR test result 
were excluded (Fig. 1)). Maximum axial and sagittal body diameters of 
patients’ chest CTs were measured to assess body size. 
2.2. Technical CT parameters 
We established chest CT examinations with new low-dose protocols 
immediately when the first cases of COVID-19 appeared. Parameters for 
the protocols were selected on the basis of published data and our 
center’s experience with clinical CT protocols (Table 1) [14,21–24]. At 
each site of our center, all patients who were positive for SARS-CoV-2 or 
highly suspected of having COVID-19 were examined on a CT scanner 
equipped with these low-dose-protocols (Table 1). 
2.3. Subjective image quality 
Two experienced radiologists with 5 and 10 years of expertise in the 
evaluation of chest CTs independently read the scans and scored image 
quality/diagnostic confidence regarding the presence of typical pul-
monary COVID-19 CT findings (peripheral GGO, consolidations, etc.) on 
a 3-point Likert scale (1-no diagnosis possible, 2-limited diagnostic 
confidence, 3-full diagnostic confidence). 
2.4. Objective image quality 
For objective image quality analysis, two experienced readers in 
consensus manually placed circular regions of interest (ROIs) in normal 
lung, surrounding air, and, if present, GGO and consolidation while 
carefully avoiding interfering structures such as larger blood vessels or 
airways. Example positions of ROIs are shown in Fig. 2. 
We calculated ROI-based signal-to-noise ratio (SNR) of normal lung 
and contrast-to-noise ratios (CNRs) of GGO to normal lung and consol-
idations to normal lung. 
SNR was defined as: 
SNR =
|mean HU normal lung|
SD HU surrounding air 
CNRGGO to lung as: 
CNRGGO to lung =
|mean HU normal lung − mean HU GGO|
SD HU surrounding air 
CNRconsolidation to lung as: 
CNRconsolidation to lung =
|mean HU normal lung − mean HU consolidation|
SD HU surrounding air 
Measurements were done in lung kernel reconstructions of 0.625 mm 
(GE Lightspeed VCT) or 1 mm (Canon Aquilion Prime) slice thickness, 
according to our clinical standards. 
2.5. Applied dose 
Effective dose (ED) was estimated with CT-Expo 2.5® software (Dr. 
rer. nat. Georg Stamm, Medizinische Hochschule Hannover, Hannover, 
Germany) based on the CTDIvol and DLP extracted from the dose reports. 
It was in line with calculations by multiplying the dose-length-product 
(DLP) by 0.0144 mSv/mGy cm as the conversion factor for thoracic 
imaging according to ICRP (International Commission on Radiological 
Protection) 103 [25]. 
Table 1 
Detailed technical parameters of the two CT scanners investigated: The pa-
rameters were chosen on the basis of published experience and experience at our 
center.   
GE Light-Speed VCT Canon Aquilion Prime 
Voltage 100 kVp 100 kVp 
Tube current 20− 120 mA 10− 120 mA 
Noise parameter NI: 40 SD: 27 
Rotation time 0.4 s 0.35 s 
Pitch 1.375 1.388 
Recon IR level ASIR 50 AIDR 3D standard 
Collimation 64 × 0.625 mm 80 × 0.5 mm 
ATCM on on 
Recon mode slice (axial) volume 1/0.8 
Recon section 
interval 
0.625 mm 1 mm 
Field of view DFOV: depending on patient 
size 
SFOV: 50 cm 
DFOV: depending on patient 
size 
SFOV: 50 cm  
Fig. 1. Patient cohort. 
We retrospectively enrolled 36 patients from two sites (n = 17/19) of our 
central European Level-I university center. All patients included were positive 
for SARS-CoV-2 (RT-PCR of nasopharyngeal and oropharyngeal swab samples); 
patients with a negative RT-PCR test result were excluded. 
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2.6. Statistical analysis 
Calculations and graphs were created with GraphPad Prism v. 5 ® 
(GraphPad Software, San Diego, CA, USA). Based on parameter scale 
and the outcome of the Shapiro-Wilk test for normal distribution, results 
are given as mean and standard deviation (SD) or median and inter-
quartile range (IQR). 
3. Results 
3.1. Patient cohort 
The study population consisted of a total of 36 patients (men: n = 27 
(75 %), women: n = 9 (25 %)) with a mean age of 59.2 ± 15.4 years 
(range: 24–90 years) (Fig. 3). Thirty-four of 36 patients (94 %) had 
findings typical for COVID-19 in CT imaging. 
Fig. 2. Example cases of six patients with typical findings of COVID-19 in low-dose-chest CT. 
a): 75-year-old woman with peripheral GGO, ED 0.5 mSv 
b): 78-year-old man with peripheral GGO, ED 0.4 mSv 
c): 71-year-old man with peripheral GGO, ED 0.4 mSv 
d): 62-year-old man with mixed GGO and reticular pattern, ED 0.4 mSv 
e): 67-year-old man with peripheral GGO and consolidations, ED 0.4 mSv 
The red circles in E show the positions of ROIs for measurement of objective image quality 
f): 51-year-old man with peripheral GGO, ED 0.4 mSv. 
C.M. Hamper et al.                                                                                                                                                                                                                             
European Journal of Radiology Open 7 (2020) 100283
4
Maximum patient diameters were 24.7 ± 3.2 mm and 24.6 ± 3.3 mm 
(sagittal and axial orientation) (Fig. 3). 
3.2. Subjective image quality 
Thirty-four of 36 patients had typical findings of COVID-19 including 
peripheral GGO, consolidations, and/or crazy paving; however, all 36 
CT studies were rated for diagnostic confidence. The two independent 
raters scored all scans as completely confident (3 ± 0). 
3.3. Objective image quality 
Calculated SNR/CNR values for the assessment of objective image 
quality were in line with expectations based on our earlier experience 
and are consistent with subjective scoring. For all cases taken together, 
we obtained the following ratios: SNRlung: 17.0 ± 5.9, CNRGGO to lung: 7.5 
± 5.0, and CNRconsolidation to lung: 15.3 ± 6.1. For further deails see Fig. 4. 
3.4. Applied dose 
CTDIvol was 0.9 ± 0.3 mGy, retrospectively resulting in a DLP of 35 ±
10.2 mGy*cm and a median ED of 0.5 mSv (IQR: 0.2 mSv, range: 
0.3− 0.9 mSv) (Fig. 5). Mean ED was 0.5 ± 0.2 mSv (Fig. 5). 
4. Discussion 
As CT is frequently used in patients with COVID-19 the risks asso-
ciated with radiation exposure should be taken into account, especially 
in younger patients [14]. Following the ALARA principle, a low-dose 
approach to CT scanning is necessary without sacrificing the diag-
nostic confidence. The aim of our study was therefore to identify CT 
parameter settings that fulfil these requirements. 
The sex distribution of COVID-19 patients in our study - 75 % men 
and 25 % women - fits to results in literature [26]. In the study of Huang 
et al., 73 % of patients with COVID-19 were male, whereas in the study 
of Itelman et al., 65 % of the affected patients were male [4,27]. 
The mean age of our patients was 59.2 ± 15.4 years (range 24–90 
years), which is consistent with the results of other studies such as that of 
Yang et al., who showed that COVID-19 affects all age groups. In their 
multicenter study on 8.866 patients, including 4.021 confirmed COVID- 
19 patients, nearly half of the patients (47.7 %) were older than 50 
years, Yi et al. reported [19]. Itelman et al. found a mean age of 52 ± 20 
years in 162 patients in Israel [27]. 
In our study, 94 % of the patients (34/36) with positive RT-PCR 
testing had typical pulmonary CT findings associated with COVID-19. 
Pan et al. analyzed typical findings in patients with COVID-19 over 
time from initial diagnosis to recovery. They concluded that pulmonary 
manifestations were most severe 10 days after the first symptoms [28]. 
Of note, four patients did not have typical findings in their initial chest 
CT but later on [28]. Kanne et al. also show that up to around 50 % of 
patients with COVID-19 do not have abnormal CT scans in the first two 
days after onset of symptoms [29]. Thus, the two negative CT scans in 
our study may be attributable to an early stage of the disease. 
In our study the readers consistently assigned the highest diagnostic 
confidence to all scans. Dangis et al. also investigated subjective eval-
uation of CT images and concluded, that submillisievert chest CT allows 
for assessment of COVID-19 in patients at the emergency room (ER) 
[21]. 
In our study, we additionally determined CNR and SNR for objective 
image quality assessment, and the results underline our subjective 
impression. SNRlung was 17.0 ± 5.9, CNRGGO to lung 7.5 ± 5.0, and 
CNRconsolidation to lung 15.3 ± 6.1. Comparable to our results, Agostini 
et al. found a median SNRlung of 12.2 (range 9.83–14.21) [22]. Kang 
et al. reported an SNR of 0.47 and CNR of 1.09 for their low-dose pro-
tocol but did not give details on calculation [14]. 
In each of our 36 patients, ED was lower than 1 mSv with a median of 
0.5 mSv (IQR: 0.2mSv, range: 0.3− 0.9 mSv) and a mean ED of 0.5 ± 0.2 
mSv. Kang et al. compared two adult patients with COVID-19 of similar 
height, body size, and age examined in a Siemens scanner. One was 
examined with a low-dose CT protocol, the other with a standard-dose 
protocol. ED in the low-dose-protocol was 0.203 mSv whereas, in our 
study of 36 patients, the lowest ED was 0.3 mSv. Furthermore, Kang 
et al. only examined two patients and did not report details of patients’ 
age, height, and body size [14]. Agostini et al. examined ten patients 
with COVID-19 using a standard-dose and a low-dose protocol. Median 
ED was 0.28 mSv (range 0.25− 0.42 mSv) with their low-dose protocol at 
100 kVp on a Siemens scanner [22]. Dangis et al. achieved a mean ED of 
0.58 ± 0.25 mSv in chest CT examinations with a low-dose protocol of 
83 patients with COVID-19, which is comparable to our results [21]. Our 
mean CTDIvol was 0.9 ± 0.3 mGy, which is higher than that of 0.39 mGy 
reported by Kang et al. [14]. The median CTDIvol in the study of Agostini 
et al. was also lower at 0.64 mGy (range 0.47–1.12 mGy) [22]. Dangis 
et al. had a higher mean CTDIvol of 1.33 ± 0.55 mGy in a group of 83 
patients with COVID-19 [21]. Our mean DLP was 35 ± 10.2 mGy*cm, 
which is again above that of Kang et al. [14], which was 14.5 mGy*cm, 
and the median DLP reported by Agostini et al. was also lower at 19.5 
mGy*cm (17.5–29.02 mGy*cm) [22]. Our median DLP was lower than 
that of 41.4 ± 17.7 mGy*cm reported by Dangis et al. in a group of 83 
patients with COVID-19 [21]. In sum, published results for ED, CTDIvol 
and DLP are comparable to our results and thus appear to be robust for a 
mid-European patient collective. Differences may be due to variations in 
patient size or other technical parameter settings (e.g. iterative recon-
struction level). Of course, if CT is not performed for COVID-19 diag-
nosis alone and there are additional questions to be answered (e.g., 
Fig. 3. a) Age and b) body diameter distribution in the patient population. 
Mean patient age was 59.2 years; mean diameters were 24.7 cm and 24.6 cm in a sagittal and axial orientation, respectively. 
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pulmonary embolism), administration of contrast medium and use of 
higher dose settings could be necessary. 
The main limitation of our study is the small sample size of 36 pa-
tients and the retrospective, single-center design. Furthermore, we only 
evaluated two CT scanners, and the readers were not blinded to tech-
nical parameters or the diagnosis. We only included patients > 18 years 
and did not compare low-dose with normal-dose chest CT. In addition, 
the results probably cannot be transferred to patients with larger body 
diameters and dedicated studies should be performed. 
In conclusion, the presented parameter settings allow acquisition of 
chest CT scans with dose exposure in the submillisievert range on the 
two CT scanners used in our study without sacrificing diagnostic con-
fidence regarding the presence of typical pulmonary changes associated 
with COVID-19. 
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